Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.23%
1,103.83
-2.53
-0.23%
—1,106.361,105.681,109.291,104.25——
SIXC
Communications
SIXC
Communications
SIXC
+0.58%
613.85
+3.56
+0.58%
—610.29610.29613.92610.29——
SIXE
Energy
SIXE
Energy
SIXE
+0.04%
1,211.71
+0.49
+0.04%
—1,211.221,211.011,212.241,209.79——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.14%
1,753.08
+2.37
+0.14%
—1,750.711,753.101,757.861,753.10——
SIXM
Financials
SIXM
Financials
SIXM
+0.80%
633.22
+5.05
+0.80%
—628.17629.38633.75629.38——
SIXR
Staples
SIXR
Staples
SIXR
+0.42%
858.18
+3.61
+0.42%
—854.57855.71858.11855.71——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.28%
217.47
+0.60
+0.28%
—216.87216.87217.75216.87——
SIXT
Technology
SIXT
Technology
SIXT
+0.26%
3,571.10
+9.16
+0.26%
—3,561.943,571.443,574.033,562.15——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.01%
903.41
+0.100
+0.01%
—903.31903.26904.33903.26——
SIXV
Health care
SIXV
Health care
SIXV
-0.05%
1,480.83
-0.71
-0.05%
—1,481.541,482.481,483.831,480.62——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.50%
2,411.92
+11.97
+0.50%
—2,399.952,404.452,412.722,404.45——
NVAX:NASDAQ
Novavax Inc
$8.92
-3.47%
(-0.32) 1D
May 14, 9:38:42 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NVAX...
Open
$9.16
High
$9.31
Low
$8.86
Mkt. cap
1.48B
Avg. vol.
4.46M
Volume
43.87K
52-wk high
$11.97
52-wk low
$5.96
EPS
-$0.58
Beta
2.37
Shares outstanding
164.44M
No. of employees
749
News stories
From sources across the web
Profile
Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. The company also develops vaccines for influenza, respiratory syncytial virus, avian flu, shingles, Clostridioides difficile, and malaria. Novavax develops proprietary immune-stimulating saponin-based immunologic adjuvants at a wholly owned Swedish subsidiary, Novavax AB. One of these, Matrix-M, is used in the Novavax COVID-19 vaccine. Wikipedia
About Novavax Inc
CEOJohn C. Jacobs
Employees749
Founded1987
HeadquartersGaithersburg, Maryland, United States
SectorBiotechnology
Websitenovavax.com
Last report
May 6, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
-$0.06 / -$0.37
+83.78%beat
Revenue / Est. (USD)
139.51M / 79.81M
+74.82%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
239.24M
70.44M
147.14M
139.51M
Cost of goods sold
80.29M
103.70M
135.96M
112.43M
Cost of revenue
80.29M
103.70M
135.96M
112.43M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
53.28M
46.12M
-9.76M
37.12M
Operating expense
53.28M
46.12M
-9.76M
37.12M
Total operating expenses
133.57M
149.82M
126.20M
149.54M
Operating income
105.67M
-79.38M
20.94M
-10.03M
Other non operating income
202.00K
178.00K
53.37M
525.00K
EBT including unusual items
107.45M
-203.04M
17.90M
-8.51M
EBT excluding unusual items
112.05M
-75.68M
29.41M
-3.11M
Income tax expense
946.00K
-657.00K
376.00K
985.00K
Effective tax rate
0.88%
0.32%
2.10%
-11.58%
Other operating expenses
-
-
-
-
Net income
106.51M
-202.38M
17.53M
-9.49M
Net profit margin
44.52%
-287.29%
11.91%
-6.80%
Earnings per share
0.62
-0.47
0.11
-0.06
Interest and investment income
7.00M
7.20M
-
7.10M
Interest expense
-5.52M
-5.48M
-27.99M
-4.90M
Net interest expenses
1.48M
1.72M
-27.99M
2.20M
Depreciation and amortization charges
-
-
-
-
EBITDA
113.23M
-72.80M
26.06M
-6.97M
Gain or loss from assets sale
-
97.04M
807.00K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer